C. Vogel et al., TRANSFORMING GROWTH FACTOR-BETA(1) INHIBITS TCDD-INDUCED CYTOCHROME P450IA1 EXPRESSION IN HUMAN LUNG-CANCER A549 CELLS, Archives of toxicology, 68(5), 1994, pp. 303-307
The effect of transforming growth factor-beta(1) (TGF-beta 1) on the e
xpression of cytochrome P450IA1 (CYPIA1) was examined in 2,3,7,8-tetra
chlorodibenzo-p-dioxin (TCDD)-treated human lung cancer A549 cells. Us
ing the reverse transcription-polymerase chain reaction (RT-PCR) it wa
s demonstrated that TGF-beta(1) inhibits CYPIA1 expression in a dose d
ependent manner. Based on the inhibitory concentration 50 (IC50) of ab
out 5 pM it is suggested that TGF-beta(1) has a physiological function
in downregulation of this cytochrome. In the presence of cycloheximid
e, the effect of TGF-beta(1) on CYPIA1 mRNA disappeared. This finding
indicates that protein synthesis may be required for the TGF-beta(1) m
ediated response of CYPIA1. The possible mechanisms by which TGF-beta(
1) interacts with TCDD-responsive drug metabolizing enzymes are discus
sed.